Middle East and Africa Farm Animal Drugs Market

The Middle East & Africa farm animal drugs market is expected to reach US$ 893.5 million by 2028 from US$ 609.7 million in 2021. The market is estimated to grow at a CAGR of 5.6% from 2021–2028.

Consumers are becoming increasingly aware and concerned about the welfare of animals raised for food. This has put pressure on suppliers to ensure that animals entering their systems are treated humanely. Measures are being taken for addressing such demand. Only one drug is approved in the US to control interdigital phlegmon (foot rot) pain in non-lactating cattle. Therefore, using medications for pain management in elective procedures, such as dehorning and castration, in cattle or analgesia in lactating dairy cows and pigs is considered an extra-label drug use. It is regulated as per the clarification on the use of veterinary drugs law. Flunixin, meloxicam, and ketoprofen are nonsteroidal anti-inflammatory drugs with supportive research on on-farm analgesia. Several products, such as local and regional anesthetics, opioids, and nonsteroidal anti-inflammatory drugs (NSAIDs), are available in the market to relieve pain in animals.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the farm animal drugs market. The Middle East & Africa farm animal drugs market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Farm animal drugs Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report Request Free Sample PDF

Middle East and Africa Farm Animal Drugs Strategic Insights

Strategic insights for the Middle East and Africa Farm Animal Drugs provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Farm Animal Drugs Report Scope

Middle East and Africa Farm Animal Drugs Regional Insights

The geographic scope of the Middle East and Africa Farm Animal Drugs refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

• Anti-Infective
• Parasiticides
• Anti-inflammatory
• Anesthetics
• Analgesics
• Hormones and Related Products
• Others

•  Livestock Animal
• Equine 

By Route of Administration

•  Oral
• Parenteral
• Topical
• Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Others

By Country

• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

   

Companies Mentioned

• PHIBRO ANIMAL HEALTH CORPORATION
• Zoetis Inc.
• Ceva
• Elanco
• Virbac
• INTAS PHARMACEUTICALS LTD.
• Alembic Pharmaceuticals Limited
• Boehringer Ingelheim International GmbH
• MSD Animal Health